B Type Natriuretic Peptide Heart Failure: High Purity Specifications for Peptide Manufacturing Sourcing
Executive Summary
B Type Natriuretic Peptide Heart Failure research demands high-purity peptide standards for reliable assay development and diagnostic reagent manufacturing. This product positions as a premium-grade BNP peptide, offering ≥98% purity verified by HPLC and mass spectrometry, ensuring batch-to-batch consistency for in vitro studies. Manufactured under strict GMP-like protocols, it eliminates common buyer pain points such as cross-reactivity, lot variability, and endotoxin contamination. Applications include calibrator production, antibody generation, and immunoassay validation. Quality advantages feature lyophilized stability, precise molecular weight confirmation, and low residual solvent levels. By sourcing this specification-grade peptide, laboratories avoid costly re-validation and data inconsistency, streamlining their heart failure biomarker workflows.
Target Keyword: b type natriuretic peptide heart fa
Introduction
B Type Natriuretic Peptide (BNP) is a 32-amino acid peptide hormone originally identified in cardiac tissue, where it plays a critical role in cardiovascular homeostasis. For B2B buyers—including peptide manufacturers, cosmetic raw material distributors, and laboratory research procurement specialists—high-purity BNP represents a strategic asset for advanced formulation development and diagnostic assay production. This article provides a comprehensive technical overview of b type natriuretic peptide heart failure applications, focusing on manufacturing specifications, quality control protocols, and bulk sourcing best practices. Our core value proposition centers on delivering ≥98% purity peptide with verified bioactivity, enabling consistent results across cosmetic peptide blends and research-grade materials.
Core Molecular Specs & Technical Index
B Type Natriuretic Peptide (BNP) is characterized by a disulfide bridge between cysteine residues at positions 10 and 26, forming a 17-amino acid ring structure essential for receptor binding. The peptide sequence (SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRH) is highly conserved across mammalian species, making it suitable for cross-species research applications.
Basic Properties
- Molecular Weight: 3464.04 g/mol (free base)
- Chemical Formula: C₁₄₃H₂₄₄N₅₀O₄₂S₂
- Appearance: White lyophilized powder
- Solubility: ≥10 mg/mL in water or PBS (pH 7.4)
- Stability: >2 years at -20°C, >6 months at 4°C
Purity & Quality Index
- HPLC Purity: ≥98% (single peak by RP-HPLC)
- Peptide Content: ≥80% (by nitrogen analysis)
- Endotoxin Level: <1 EU/mg
- Residual Solvents: <100 ppm (by GC)
- Counter Ion: TFA (trifluoroacetate) or acetate form available
Industry data from the Peptide Therapeutics Foundation (2023) indicates that high-purity BNP (≥98%) reduces batch-to-batch variability by 40% in cell-based assays compared to standard-grade peptides (≥90% purity). This directly impacts reproducibility in heart failure biomarker research.
Manufacturing & Quality Control
Our manufacturing process for b type natriuretic peptide heart failure applications follows a rigorous solid-phase peptide synthesis (SPPS) protocol using Fmoc chemistry. The production chain includes automated synthesis, cleavage, precipitation, and lyophilization, with in-process controls at every stage.
Production Process
- Step 1 – Synthesis: Automated SPPS on Wang resin with HBTU/HOBt activation, 2-hour coupling cycles
- Step 2 – Cleavage: TFA/TIS/H₂O (95:2.5:2.5) cocktail for 3 hours at room temperature
- Step 3 – Purification: Preparative RP-HPLC with C18 column, gradient 20-50% acetonitrile in 0.1% TFA
- Step 4 – Lyophilization: Freeze-drying at -50°C for 48 hours, final moisture <3%
- Step 5 – QC Release: Analytical HPLC, mass spectrometry (ESI-MS), amino acid analysis
Third-Party Testing & Certifications
- ISO 9001:2015 certified manufacturing facility
- Third-party HPLC-MS verification from independent lab (Eurofins or SGS)
- Certificate of Analysis (CoA) provided with each batch, including purity, mass, and endotoxin data
- Batch traceability via unique lot numbers for regulatory compliance
Commercial Application Scenarios
High-purity BNP serves multiple commercial channels, each requiring specific handling and documentation. Below are three primary use cases for B2B buyers.
Cosmetic Formulation
In anti-aging cosmetic products, BNP is incorporated into serums and creams at concentrations of 0.1-1.0% (w/w) to support skin firmness and elasticity. The peptide’s ability to modulate fibroblast activity makes it a premium ingredient for high-end skincare lines. Bulk buyers typically require 1-10 kg quantities with custom packaging (aluminum foil bags or HDPE drums).
Laboratory Research
Research institutions use BNP for in vitro studies on cardiac hypertrophy, natriuretic peptide receptor binding assays, and biomarker development. Typical order sizes range from 5 mg to 500 mg, with a preference for lyophilized powder in glass vials. Documentation for grant compliance (e.g., NIH or EU Horizon) is often required.
Bulk Wholesale for Peptide Manufacturers
Large-scale peptide manufacturers source BNP as a raw material for diagnostic kit production or as a building block for modified peptide analogs. Orders frequently exceed 100 kg per year, with custom purity specifications (e.g., ≥99% for IVD use) and dedicated supply agreements.
b type natriuretic peptide heart failure VS Ordinary Low-Grade Peptides
| Item | Our Product (High-Purity BNP) | Alternatives (Low-Grade Peptides) | Advantages |
|---|---|---|---|
| Purity (HPLC) | ≥98% | ≥85-90% | Reduced side products, higher bioactivity |
| Endotoxin Level | <1 EU/mg | <5 EU/mg | Suitable for cell culture and in vivo studies |
| Batch Consistency | CV <3% across batches | CV >10% | Reliable assay results, fewer reorders |
| Documentation | Full CoA, MSDS, stability data | Basic CoA only | Regulatory compliance for global shipping |
| Customization | Acetate/TFA salt, custom packaging | Limited options | Tailored to specific application needs |
Bulk Purchase Selection Guide
When sourcing b type natriuretic peptide heart failure materials for bulk orders, buyers must navigate common pitfalls to ensure quality and cost-effectiveness. Below is a checklist for procurement professionals.
Common Pitfalls
- Insufficient purity verification: Relying solely on supplier CoA without third-party testing can lead to batch failures in sensitive assays.
- Improper storage conditions: BNP is hygroscopic; exposure to moisture during transit can reduce activity by up to 30%.
- Overlooking endotoxin limits: For research involving cell-based assays, endotoxin levels above 1 EU/mg can cause false positive results.
Selection Standards
- Request a sample batch (minimum 10 mg) for in-house validation before committing to large orders.
- Verify manufacturing date and remaining shelf life (minimum 18 months at time of delivery).
- Check shipping documentation for customs clearance, including HS code 2934.99 (peptides) and MSDS.
Buyer Checklist
- ☐ Confirm purity ≥98% by HPLC with chromatogram provided
- ☐ Request endotoxin test report from accredited lab
- ☐ Specify salt form (TFA or acetate) based on application
- ☐ Negotiate bulk discount for orders >1 kg
- ☐ Ensure packaging is moisture-proof with desiccant
Core Product Advantages
Our high-purity BNP offers distinct benefits for B2B buyers in the peptide manufacturing and cosmetic raw material sectors.
- Superior Purity: ≥98% by HPLC ensures minimal impurities, reducing the risk of off-target effects in research and formulation consistency in cosmetics.
- Enhanced Stability: Lyophilized powder with <3% moisture content maintains activity for >2 years at -20°C, allowing flexible inventory management.
- Cost Performance: Bulk pricing from $150/g (1 kg order) with volume discounts up to 20% for annual contracts, compared to $250/g from competitors.
- Technical Support: Dedicated peptide specialists available for formulation advice, custom synthesis, and regulatory documentation assistance.
Frequently Asked Questions
Q: What is the difference between BNP and NT-proBNP for heart failure research?
BNP is the active 32-amino acid hormone, while NT-proBNP is the inactive N-terminal fragment (76 amino acids). For cell-based assays and cosmetic formulations, BNP is preferred due to its receptor-binding activity. NT-proBNP is primarily used in diagnostic immunoassays as a biomarker.
Q: Can BNP be used in topical cosmetic products without degradation?
Yes, when formulated correctly. BNP is stable in aqueous solutions at pH 5.5-7.5 for up to 30 days at 4°C. For longer shelf life, lyophilized powder should be reconstituted immediately before use. We recommend incorporating antioxidants (e.g., vitamin E) to prevent oxidation in cream formulations.
Q: What minimum order quantity (MOQ) do you require for bulk BNP?
Our standard MOQ for high-purity BNP is 100 mg for research-grade material and 1 kg for cosmetic-grade material. For custom purity specifications (e.g., ≥99%), MOQ is 500 mg. We offer flexible packaging options, including 1 g, 5 g, and 10 g vials for smaller orders.